Abstract:The activation of pregnane X receptor (PXR), a member of the nuclear receptor (NR) superfamily, can mediate potential drugdrug interactions, and therefore, prediction of PXR activation is of great importance for evaluating drug metabolism and toxicity. In this study, based on 532 structurally diverse compounds, we present a comprehensive analysis with the aim to build accurate classification models for distinguishing PXR activators from nonactivators by using a naive Bayesian classification technique. First, the distributions of eight important molecular physicochemical properties of PXR activators versus nonactivators were compared, illustrating that the hydrophobicity-related molecular descriptors (AlogP and log D) show slightly better capability to discriminate PXR activators from nonactivators than the others. Then, based on molecular physicochemical properties, VolSurf descriptors, and molecular fingerprints, naive Bayesian classifiers were developed to separate PXR activators from nonactivators. The results demonstrate that the introduction of molecular fingerprints is quite essential to enhance the prediction accuracy of the classifiers. The best Bayesian classifier based on the 21 physicochemical properties, VolSurf descriptors, and LCFC_10 fingerprints descriptors yields a prediction accuracy of 92.7% for the training set based on leave-one-out (LOO) cross-validation and of 85.2% for the test set. Moreover, by exploring the important structural fragments derived from the best Bayesian classifier, we observed that flexibility is an important structural pattern for PXR activation. In addition, chemical compounds containing more halogen atoms, unsaturated alkanes chains relevant to pi-pi stacking, and fewer nitrogen atoms tend to be PXR activators. We believe that the naive Bayesian classifier can be used as a reliable virtual screening tool to predict PXR activation in the drug design and discovery pipeline.

Special Section on New and Emerging Areas and Technologies in Drug Metabolism and Disposition, Part II Exogenous Pregnane X Receptor Does Not Undergo Liquid-Liquid Phase Separation in Nucleus under Cell-Based in Vitro ConditionsS

Exogenous Pregnane X Receptor Does Not Undergo Liquid-liquid Phase Separation in Nucleus under Cell-based In Vitro Conditions

Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor {alpha} Do Not Perform Liquid-Liquid Phase Separation in Cells

[Coexpression of PXRLBD with SRC88 and Construction of Equilibrium Dialysis Model of Screening PXR Ligands].

PPARγ phase separates with RXRα at PPREs to regulate target gene expression

The role of pregnane X receptor (PXR) in substance metabolism

Human pregnane X receptor-mediated transcriptional regulation of cytochrome P450 3A4 by some phytochemicals]

CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation

Functions of Pregnane X Receptor in Self-Detoxification

Evaluation of a novel PXR-knockout in HepaRG™ cells

Genistein,coumestrol and quercetin activate pregnane X receptor-mediated transcription of CYP3A4

Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Progresses of researches on the correlation between pregnane X receptor and CYP3A

Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis

PXR-mediated Organophorous Flame Retardant Tricresyl Phosphate Effects on Lipid Homeostasis

Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats

Dietary phytochemicals as modulators of human pregnane X receptor

Xenobiotic Receptors Car and Pxr

Induction of Rat Hepatic Cytochrome P-450 3A by Zolmitriptan Mediated with Pregnane X Receptor

Regulation of drug resistance by human pregnane X receptor in breast cancer.

Serine 350 of Human Pregnane X Receptor is Crucial for Its Heterodimerization with Retinoid X Receptor Alpha and Transactivation of Target Genes in Vitro and in Vivo.